Tan Lek-Hong, Chen Pei-Shan, Chiang Hsiu-Yin, King Emily, Yeh Hung-Chieh, Hsiao Ya-Luan, Chang David Ray, Chen Sheng-Hsuan, Wu Min-Yen, Kuo Chin-Chi
Department of Urology, China Medical University Hospital and College of Medicine, China Medical University, Taichung, Taiwan.
Big Data Center, China Medical University Hospital and College of Medicine, China Medical University, Taichung, Taiwan.
Kidney Med. 2022 Mar 31;4(5):100458. doi: 10.1016/j.xkme.2022.100458. eCollection 2022 May.
RATIONALE & OBJECTIVE: Poor sleep quality and insomnia are pervasive among patients with advanced chronic kidney disease (CKD); however, these health issues have not been systematically evaluated.
Systematic review and meta-analysis.
SETTING & STUDY POPULATIONS: Adult patients with CKD not receiving kidney replacement therapy (KRT), as well as adults receiving KRT, including hemodialysis, peritoneal dialysis, and kidney transplantation.
A systematic literature search using PubMed, Embase, and PsycNET, was conducted for articles published between January 1, 1990, and September 28, 2018.
Data on the prevalences of poor sleep quality and insomnia in patients with CKD, including those receiving and not receiving KRT, were extracted.
Pooled prevalences were estimated using a random-effects meta-analysis and were stratified according to age, CKD stage, World Health Organization region, risk of bias, Pittsburgh Sleep Quality Index score, and the different criteria for insomnia that were used at diagnosis.
Of 3,708 articles, 93 were selected, and significant methodological heterogeneity was present. The pooled prevalences of poor sleep quality for CKD without KRT, hemodialysis, peritoneal dialysis, and kidney transplantation were 59% (95% CI, 44%-73%), 68% (95% CI, 64%-73%), 67% (95% CI, 44%-86%), and 46% (95% CI, 34%-59%), respectively. The corresponding prevalences of insomnia were 48% (95% CI, 30%-67%), 46% (95% CI, 39%-54%), 61% (95% CI, 41%-79%), and 26% (95% CI, 9%-49%), respectively. Insomnia was significantly more prevalent among patients aged 51-60 years and those aged >60 years than among those aged <50 years. The prevalence of insomnia in the European region was the lowest of all World Health Organization regions.
High interstudy heterogeneity.
Approximately half of the patients with advanced CKD had poor sleep quality or insomnia, and the prevalence was even higher among those who received KRT. Kidney transplantation may reduce the burden of poor sleep quality and insomnia.
睡眠质量差和失眠在晚期慢性肾脏病(CKD)患者中普遍存在;然而,这些健康问题尚未得到系统评估。
系统评价与荟萃分析。
未接受肾脏替代治疗(KRT)的成年CKD患者,以及接受KRT的成年人,包括血液透析、腹膜透析和肾移植患者。
使用PubMed、Embase和PsycNET对1990年1月1日至2018年9月28日发表的文章进行系统文献检索。
提取CKD患者(包括接受和未接受KRT的患者)睡眠质量差和失眠患病率的数据。
采用随机效应荟萃分析估计合并患病率,并根据年龄、CKD分期、世界卫生组织区域、偏倚风险、匹兹堡睡眠质量指数评分以及诊断时使用的不同失眠标准进行分层。
在3708篇文章中,筛选出93篇,存在显著的方法学异质性。未接受KRT的CKD患者、血液透析患者、腹膜透析患者和肾移植患者睡眠质量差的合并患病率分别为59%(95%CI,44%-73%)、68%(95%CI,64%-73%)、67%(95%CI,44%-86%)和46%(95%CI,34%-59%)。相应的失眠患病率分别为48%(95%CI,30%-67%)、46%(95%CI,39%-54%)、61%(95%CI,41%-79%)和26%(95%CI,9%-49%)。51-60岁和60岁以上患者的失眠患病率显著高于50岁以下患者。欧洲区域的失眠患病率在所有世界卫生组织区域中最低。
研究间异质性高。
约一半的晚期CKD患者存在睡眠质量差或失眠,接受KRT的患者患病率更高。肾移植可能减轻睡眠质量差和失眠的负担。